Session 1 - Meningococcal burden of disease

Welcome Remarks - Bruce Gellin, Sabin Vaccine Institute

Global Burden of invasive meningococcal diseases - Olivier Ronveaux, WHO

Epidemiology of meningococcal disease in the Latin American Region - Lucia Helena de Oliveira, PAHO

Epidemiology of meningococcal disease in;

Argentina - Angela Gentile, Universidad de Buenos Aires

Brazil - Camile Moraes, Ministry of Health, Brazil 

 

Session II - Meningococcal vaccines

Meningococcal vaccines - Marco Aurelio Safadi, Faculdade de Ciências Médicas da Santa Casa

Meningococcal vaccines: A review of the effectivness and impact - Lucia Helena de Oliveira, PAHO

 

Session III - Vaccination recommendations for groups at increased risk of MD

Panel participants:

Maria Catalina Pirez, Universidad de la República Uruguay

Enrique Casanueva, Austral University, Argentina

 

Session IV - Epidemiological surveillance models

Overview of surveillance systems - Maria Tereza da Costa Oliveira, PAHO

Review of meningococcal epidemiological surveillance - Olivier Ronveaux, WHO

Review of meningococcal laboratory surveillance - Marcio Galvao, Fundação Oswaldo Cruz - FIOCRUZ

Novel molecular tools for meningococcal disease surveillance - Ivano de Filippis, Fundação Oswaldo Cruz - FIOCRUZ

 

Session V - How to handle an outbreak

Meningococcal outbreak in Chile - Rodolfo Villena, University of Chile

Meningococcal outbreak in Brazil - Marco Aurelio Safadi, Faculdade de Ciências Médicas da Santa Casa

Insights from meningococcal disease outbreaks - Lucy McNamara, Centers for Disease Control and Prevention, USA

 

Session VI - Meningococcal vaccines in Argentina and Brazil, national immunization program experience

Panel participants:

Cristian Biscayart, Ministry of Health, Argentina

Carla Domingues, Ministry of Health, Brazil

 

Session VII - Challenges in research

Pharmacoeconomic aspects of Meningococcal Disease - Norberto Giglio, Hospital de Niños Ricardo Gutiérrez

Meningococcal surveillance systems: foundation for addressing broader questions - Lucy McNamara, Centers for Disease Control and Prevention

Summary and closing remarks